Investigation of Immune Marker Expression Post Pam3CSK4 Stimulation
This study evaluates the expression levels of key immune markers such as CXCL16, CD36, LOX-1, and SR-B1 following treatment with Pam3CSK4. We monitored the cell responses across various concentrations to establish a correlation between treatment dose and immune activation markers. The findings are expected to provide insights into the immune modulation effects of Pam3CSK4 and its potential applications in therapeutic strategies targeting immune regulation.
Investigation of Immune Marker Expression Post Pam3CSK4 Stimulation
E N D
Presentation Transcript
C CXCL16 CD36 LOX-1 SR-B1 102 102 102 103 103 103 104 104 104 101 101 101 101 102 103 100 100 100 100 100 100 100 100 101 101 101 101 102 102 102 102 103 103 103 103 104 104 104 104 104 With DEP Medium alone D 100 100 100 100 60 60 60 60 60 60 60 60 40 40 40 40 20 20 20 20 DEP+ Pam3CisK4 0 0 0 0 Counts Pam3CSK4 Counts CXCL16 CD36 LOX-1 SR-B1 Counts Counts